Related Experiment Videos
Phase II trial of AMSA in prostatic cancer
Cancer Treatment Reports
|January 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2005
Gemcitabine and taxane combinations in non small-cell lung cancer.
Clinical lung cancer·2004
Characterization of inorganic coordination complexes by matrix-assisted laser desorption/ionization mass spectrometry.
Rapid communications in mass spectrometry : RCM·2001
Phase 1 drug interaction study of suramin and warfarin in patients with prostate cancer.
American journal of clinical oncology·2001
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
Pharmacological management of obesity: Current landscape and emerging therapies.
Indian journal of pharmacology·2026
Engineered human adipose-derived stem cells delivering carboxylesterase and TRAIL for castration-resistant prostate cancer: Translational synthesis.
Investigative and clinical urology·2026
Synergistic effects of sorafenib and cilostazol in HepG2 cells.
Journal of biosciences·2026
Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer.
Molecular oncology·2026